Clinical experience with infliximab biosimilar in psoriasis. [electronic resource]
- The British journal of dermatology 12 2017
- e347-e348 p. digital
Publication Type: Letter
1365-2133
10.1111/bjd.15755 doi
Antibodies, Monoclonal--therapeutic use Biosimilar Pharmaceuticals--therapeutic use Dermatologic Agents--therapeutic use Drug Substitution Female Humans Infliximab--therapeutic use Male Middle Aged Psoriasis--drug therapy Treatment Outcome